Jpmorgan Chase & CO Dare Bioscience, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $0.61 $2 - $6	10 Added 4.18%	249 $0
Q1 2024 May 10, 2024	SELL	$0.31 - $0.57 $3,737 - $6,871	-12,055 Reduced 98.06%	239 $0
Q4 2023 Feb 12, 2024	BUY	$0.29 - $0.53 $3,535 - $6,460	12,190 Added 11721.15%	12,294 $3,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.91 $47 - $94	104 New	104 $0
Q1 2023 May 11, 2023	BUY	$0.87 - $1.36 $8,141 - $12,726	9,358 New	9,358 $9,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.